Dualyx

Egle Therapeutics

This biotechnology company develops precision medicines that modulate regulatory T cells to treat patients with autoimmune diseases and cancer.

Regcell

This biotechnology company develops regulatory T-cell therapies using an epigenetic reprogramming platform to treat patients with autoimmune diseases and inflammatory conditions.

TRexBio

This biotechnology company develops immunoregulatory medicines for patients with autoimmune and inflammatory diseases by decoding regulatory T cell function in human tissues.

Mozart Therapeutics

The company develops CD8 T regulatory cell modulators to treat patients with autoimmune and inflammatory diseases including type 1 diabetes.

Sitryx

This biopharmaceutical company develops oral small molecule medicines that target immune cell metabolism to treat patients with chronic autoimmune and inflammatory diseases.

Abata Therapeutics

This company develops regulatory T cell therapies to treat patients with severe autoimmune and inflammatory diseases including progressive multiple sclerosis and type 1 diabetes.

Sitryx Therapeutics

The company develops oral small molecule therapies to treat patients with autoimmune and inflammatory diseases by regulating immune cell metabolism.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.